News

Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.
While sprinkling cinnamon on food is likely safe, concentrated supplements might pose risks, especially for people taking ...
Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a ...
Most people associate laughing gas with dentists’ offices, where it’s used to ease anxiety and dull pain. While its nickname ...
Major scientific discoveries can arise from simple decisions: say, by simply looking where virtually no one else has. Such ...
But buprenorphine’s strength as a treatment is also a weakness. Buprenorphine is an opioid. Like methadone, the tightly ...
There are currently no FDA-approved treatments for FAP, a condition characterized by the proliferation of polyps in the colon and/or rectum.
Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...
In a recent study published in Food Chemistry: Molecular Sciences, researchers at the University of Mississippi center found ...
Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss medications. Lilly filed four lawsuits on Wednesday claiming telehealth ...